ArtBio
Drug Discovery · Cancer Care Centers
$222Mtotal raised · 2 rounds on record
4open roles
$132Mlatest round · Series B · Jul 2025 · 15 mo ago
1backers · F-Prime Capital
Overview
Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize their potential.
Funding and backers
Total raised
$222M
2 rounds on record
Latest round
$132M
Series B · Jul 2025 · 15 mo ago
Team
17
US Form 5500 (plan participants) · Dec 2024
Hiring now
4
+2 posted in 30 days
Backers
1
F-Prime Capital
The money's age
Due for its next round
15 months since the last round · and hiring
Momentum
30/100
hiring for its size, a new city
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 9, 2025
Certified ARTBIO Announces FDA Clearance of IND Application for Lead Alpha Radioligand Therapy AB001 · PRNewswire
Jul 29, 2025
Raised a round Series B $132M · led by Sofinnova Investments · PRNewswire
Jan 9, 2024
Partnership SpectronRx and ARTBIO Join Forces to Develop and Manufacture Clinical Supply of Novel Alpha Radioligand Therapy AB001 for Indiana and Surrounding Sta… · businesswire.com
Dec 7, 2023
Raised a round Venture round $90M · YahooFinance
2021
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Jul 2025 | $132M | Sofinnova Investments lead, B Capital lead, Omega Funds | PRNewswire |
| Venture round | Dec 2023 | $90M | — | YahooFinance |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
See how iOmx transforms deep tumor biology into breakthrough immunotherapies. Explore our pipeline, technology and careers — join us in…
OncoLens is the multidisciplinary cancer care platform for tumor boards, registry automation, AI patient identification, and oncology…
Prevention to Recovery Comprehensive Cancer Care Solutions From early detection and diagnosis to treatment and wellness all under one roof…
We deliver cutting edge cancer care in the home - reducing costs for patients, providers, and payers.
Clinical intelligence that thinks like an oncologist. Guideline-concordant decision support for cancer care.
Learn how the American Oncology Network supports value-based care and enhances oncology practices with specialized services.
Jobs
≈ $204k – $293k per year (Estimated) · Hybrid · Full-Time · 5+ years exp · Master's Degree · Cambridge
Apply
≈ $89k – $180k per year (Estimated) · Hybrid · Full-Time · 4+ years exp · PhD · Cambridge
Apply
≈ $176k – $303k per year (Estimated) · Remote (United States) · Full-Time · 12+ years exp · Bachelor's Degree · Cambridge
Apply
≈ $176k – $303k per year (Estimated) · Remote (United States) · Full-Time · 15+ years exp · PhD · Cambridge
Apply
Growth
Hiring Momentum
75/100
Scaling fast
Open positions
4
2 opened / 1 closed in 30 days
Median time-to-fill
97 days
faster than 12% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
75% ▼
Energy
25% ▲
Activity Timeline
New location: Oslo
Oct 2026
Added GMP to stack
Oct 2026
Tech stack
Technologies named in job postings at ArtBio over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
64/100
Practices & domains
GMP
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
F-Prime CapitalVia a fund
194 portfolio companies: AblePay Health, Arboretum LifeSciences, Inc., Arexera Therapeutics and 191 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
ARTBIO Announces FDA Clearance of IND Application for Lead Alpha Radioligand Therapy AB001
/PRNewswire/ -- ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of Pb212 alpha radioligand therapies (ARTs), today...
Read more
Report
ARTBIO: $132 Million Series B Raised For New Class Of Alpha Radioligand Therapies
ARTBIO, a clinical-stage radiopharmaceutical company, is focused on developing alpha radioligand therapies (ARTs) for various types of cancer. The company has secured $132 million in Series B financing, co-led by new investors Sofinnova Investments and B
Read more
Report
ARTBIO Appoints Four New Board Members, Co-Founder Transitions to Technical Advisory Board Role
Read more
Report
ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
Financing co-led by new investors Sofinnova Investments and B Capital, along with an existing investor with continued support from F-Prime, Omega Funds, and...
Read more
Report
CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials
Read more
Report
SpectronRx and ARTBIO Join Forces to Develop and Manufacture Clinical Supply of Novel Alpha Radioligand Therapy AB001 for Indiana and Surrounding States
Read more
Report
ARTBIO Raises Oversubscribed and Upsized $90 Million Series A Financing to Progress Pipeline and Isotope Technology Development for New Class of Alpha Radioligand Therapies
Financing co-led by Third Rock Ventures and an undisclosed healthcare fund, with significant investment also from existing investors F-Prime Capital and Omega...
Read more
Report
Radiopharma startup Artbio raises $90M in sign of field's momentum
The funding is indicative of investor interest in an area of drug research thatinvolves at least a dozen startups and multiple publicly traded companies.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Cambridge
Cambridge
United States
HQ
Locations
4 open roles 4 posted in 90 days 50% remote 200-500 est. staff
hires for Biotech, Energy
One Kendall Sq, B200, Suite 001, Cambridge, MA 02139
Earlier presence
Oslo, Norway